human KLK3 protein

RefSeq NM_145864

Also Known As:

KLK3 protein, human; kallikrein-related peptidase 3, human; prostate specific antigen, human

Networked: 5 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Enzymes and Coenzymes: 1
- Enzymes: 152586
  - Hydrolases: 2166
    - Peptide Hydrolases: 23957
      - Serine Proteases: 3726
        Serine Endopeptidases: 11
        Kallikreins: 2114
        Prostate-Specific Antigen: 15321
        human KLK3 protein: 5
        human KLK3 protein: 5
      - Endopeptidases: 633
        Serine Endopeptidases: 11
        Kallikreins: 2114
        Prostate-Specific Antigen: 15321
        human KLK3 protein: 5
        human KLK3 protein: 5
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Blood Coagulation Factors: 5376
      - Kallikreins: 2114
        human KLK3 protein: 5
  - Seminal Proteins: 8
    - Seminal Plasma Proteins: 25
      - Prostatic Secretory Proteins: 4
        Prostate-Specific Antigen: 15321
        human KLK3 protein: 5
Biological Factors: 2472

Experts

1.	Agbarya, Abed: 1 article (01/2021)
2.	Klein, Jonathan: 1 article (01/2021)
3.	Nasser, Nicola J: 1 article (01/2021)
4.	Mercadal, Lucile: 1 article (04/2015)
5.	Bao, Yunhua: 1 article (09/2005)
6.	Chen, Jiping: 1 article (09/2005)
7.	Peng, Weidan: 1 article (09/2005)
8.	Rauen, Katherine A: 1 article (09/2005)
9.	Sawicki, Janet A: 1 article (09/2005)
10.	Verbitsky, Amy: 1 article (09/2005)

Related Diseases

1.	Neoplasms (Cancer) 10/01/1999 - "This report reviews the interest of determining these kinetic parameters for prostate-specific antigen, human chorionic gonadotropin, alpha-fetoprotein, carcinoembryonic antigen, cancer antigen (CA) 125, and CA 15-3. A rise in tumor markers (DT) is a yardstick with which benign diseases can be distinguished from metastatic disease, and the DT can be used to assess the efficacy of treatments. "
2.	Prostatic Neoplasms (Prostate Cancer) 09/01/2005 - "To develop a more suitable transgenic mouse model for testing adenoviral-based gene therapies for prostate cancer, we generated prostate specific antigen/human CAR (PSA/hCAR) transgenic mice in which a chimeric enhancer/promoter sequence of the human PSA gene drives expression of a functional hCAR coding sequence. " 09/01/2004 - "Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients." 01/01/2021 - "Here, we review the role of tumor markers of toxicity and response to radiation therapy in patients with prostate cancer, including prostate specific antigen, human kallikrein 2, osteopontin, prostate cancer associated 3, citrulline, and others."
3.	Chronic Kidney Failure (Chronic Renal Failure) 04/01/2015 - "Apart from the prostate specific antigen, human chorionic gonadotropin and α-fetoprotein, their levels rise with chronic renal failure. "

Related Drugs and Biologics

1.	Tumor Biomarkers (Tumor Markers)
2.	Fetal Proteins (Fetoprotein)
3.	CA-125 Antigen (CA 125 Antigen)
4.	alpha Subunit Glycoprotein Hormones
5.	Carcinoembryonic Antigen
6.	Tissue Kallikreins (Tissue Kallikrein)
7.	Osteopontin
8.	Messenger RNA (mRNA)
9.	Chorionic Gonadotropin (Human Chorionic Gonadotropin)
10.	Citrulline

Related Therapies and Procedures

1.	Therapeutics
2.	Radiotherapy